)
Edge20 Feb 2026
Dollar General: The Rural Retailer Playbook
How Dollar General built a small-box empire across rural America, scaling value and convenience into one of retail's most durable business models.
Roivant Sciences
Roivant Sciences (ROIV) investor relations material
Roivant Sciences Status update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Status update summary3 Mar, 2026
Settlement overview
Announced a $2.25 billion global settlement with Moderna, resolving all global patent litigation related to COVID-19 vaccines, including a $950 million upfront payment and a $1.3 billion contingent on a Section 1498 appeal outcome.
Moderna receives a global non-exclusive license for SM-102 containing mRNA vaccines for infectious diseases, with no further royalties due beyond the lump sum payments.
Moderna consents to a judgment of infringement and no invalidity on four Genevant/Arbutus patents.
If the appeal is resolved in favor, the $1.3 billion payment is made; if overturned by the Supreme Court, funds would be returned.
The settlement is among the largest patent case outcomes in history, and if the contingent payment is made, it will be the largest disclosed pharma patent settlement and second largest in any industry.
Financial and capital allocation implications
Effective tax rate on the settlement is expected to be 10%-15%, with 60%-70% attributable to Roivant and the remainder to Arbutus and others.
Proceeds will be used to invest in the pipeline, upcoming launches, and new opportunities.
Share buyback program expanded to $1 billion, including a new $500 million authorization, with an aggressive approach to returning capital to shareholders.
The settlement provides significant near-term cash inflow and validates the IP estate.
Capital allocation for future settlements, such as with Pfizer, will balance share buybacks, pipeline investment, and business development.
Legal and strategic context
The Section 1498 appeal is expected to resolve in 18-36 months, with prior rulings in favor of the company.
Moderna's settlement covers about one-third of the global COVID vaccine market; Pfizer-BioNTech litigation remains ongoing and is expected to be pursued aggressively.
Judgment of no invalidity on patents strengthens position in the Pfizer case, though Pfizer can still challenge validity.
No specific damages sought from Pfizer disclosed; outcome of Moderna case seen as supportive but not determinative for Pfizer negotiations.
The outcome reduces uncertainty and allows focus on ongoing litigation and core business.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Roivant Sciences earnings date
Leerink Global Healthcare Conference 202611 Mar, 2026
Roivant Sciences
Next Roivant Sciences earnings date
Leerink Global Healthcare Conference 202611 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company established in 2014, dedicated to the development and commercialization of innovative medicines and technologies, particularly in the areas of inflammation and immunology. The company adopts a unique model, creating nimble and focused subsidiaries known as "Vants" for the development and commercialization of its medicines and technologies. This model has enabled Roivant to bring to market treatments like VTAMA® (tapinarof cream, 1%) for plaque psoriasis in adults, and to advance a diverse pipeline of investigational drugs across its family of companies, including fully human monoclonal antibodies and treatments for autoimmune diseases. Roivant Sciences is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage